The Report identifies major issues for implementation of new prevention options, including:
In the Report, AVAC also underscores the importance of WHO and UNAIDS getting involved in planning for the results from PrEP trials before data are available.
"WHO and UNAIDS, along with other stakeholders, need to combine their strengths now to provide leadership and coordination so that the world is ready to work with results from the many ongoing PrEP trials," said Warren.
Positive results from current vaccine, PrEP and microbicide trials will also present challenges and opportunities for other ongoing and planned HIV prevention trials.
"There has been concern that positive results from PrEP trials would require vaccine or microbicide trials to become larger, longer and more expensive, as PrEP could become a standard of prevention in these trials," said Warren. "But we believe that success in one trial will open up possibilities and options for research that could combine AIDS vaccines and other interventions as they emerge."<
|SOURCE AIDS Vaccine Advocacy Coalition|
Copyright©2009 PR Newswire.
All rights reserved